HOME >> BIOLOGY >> NEWS
Cutting-edge cancer researchers sought for international recognition

The American Association for Cancer Research now is accepting nominations for the fourth annual Kirk A. and Dorothy P. Landon Foundation-AACR Prizes.

These two major international prizes recognize seminal basic and translational cancer research discoveries at the cutting edge of scientific novelty and significance. Eligible candidates are active, recently published scientists who have made extraordinary advances in cancer research, and whose scientific innovation and creativity have contributed to new directions in these fields.

The nomination process and other details about the prizes are located on the AACR Website at http://www.aacr.org. The nomination deadline is Tuesday, August 10, 2004.

The recipient of each prize will receive an unrestricted cash award of $200,000. Both will present lectures during the 96th AACR Annual Meeting, April 16-20, 2005, in Anaheim, Calif., to stimulate and inspire their colleagues to new thinking and fresh approaches in both basic and translational cancer research.

"The Landon-AACR Prizes offer an unprecedented opportunity to recognize the best work of the top cancer research scientists today," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "We are honored to work with the Landon Foundation in sponsoring these distinguished prizes.

R. Kirk Landon, President of the Kirk A. and Dorothy P. Landon Foundation, said, "It is the goal of the foundation to bring heightened public attention to landmark achievements in the continuing effort to prevent and cure cancer. The dynamic lectures given during the AACR Annual Meeting are the perfect forum for promoting and rewarding outstanding cancer research and for motivating cancer investigators around the world. The Kirk A. and Dorothy P. Landon Foundation has been delighted with our synergistic partnership with the AACR and looks forward to honoring the accomplishments of scientists in the y
'"/>

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
23-Jul-2004


Page: 1 2

Related biology news :

1. Cutting-edge research to be presented at ASCPT pharmacology conference
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2019)... ... 2019 , ... The University of Vermont Health Network Ventures ... Series B Financing Round. , “With the commitment from the UVM fund ... and business resources to bear as we advance our biopharmaceutical products to the ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... in a live webinar on Wednesday, June 19, 2019 at ... operations teams, medical review teams, data management teams and contract research organizations (CROs) ...
(Date:5/26/2019)... , ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), ... AVXS-101, was approved for clinical use in the United States by the Food and ... gene therapy approved to treat inherited genetic disorders in the United States and the ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology ... the appointment of Biofeedback Tech Ltd as its authorised distributor for ... part of many therapeutic treatments and clinical assessment protocols to treat stress related ...
(Date:6/11/2019)... ... June 11, 2019 , ... A ... mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying ... on mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... to announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in ... exclusive ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the magic bullet ... products rely on these ingredients to create stable quality food that can withstand ... shift triggers food formulators to seek out alternatives for starches, gums and chemical ...
Breaking Biology Technology:
Cached News: